# Cardiovascular Physiology

## Overview

The cardiovascular system is a closed-loop circulatory system consisting of the heart, blood vessels, and blood. Its primary functions include oxygen and nutrient delivery, waste removal, hormone transport, temperature regulation, and maintenance of homeostasis. The system operates as two interconnected circuits: the pulmonary circulation (right heart to lungs) and systemic circulation (left heart to body tissues).

### Heart Anatomy and Structure

The heart is a four-chambered muscular pump consisting of:
- **Right atrium**: Receives deoxygenated blood from systemic circulation
- **Right ventricle**: Pumps blood to pulmonary circulation
- **Left atrium**: Receives oxygenated blood from pulmonary circulation  
- **Left ventricle**: Pumps blood to systemic circulation

**Heart Valves**:
- Tricuspid valve (right AV valve)
- Pulmonary valve (right semilunar valve)
- Mitral/bicuspid valve (left AV valve)
- Aortic valve (left semilunar valve)

**Cardiac Muscle Properties**:
- Striated, involuntary muscle
- Intercalated discs with gap junctions for electrical conduction
- Long refractory period prevents tetanic contractions
- Intrinsic rhythmicity and automaticity

## Pathophysiology

### Cardiac Cycle

The cardiac cycle consists of systole (contraction) and diastole (relaxation):

**Diastolic Phase**:
1. **Isovolumetric relaxation**: All valves closed, ventricular pressure drops
2. **Ventricular filling**: AV valves open, passive filling (80%) and atrial kick (20%)

**Systolic Phase**:
1. **Isovolumetric contraction**: AV valves close, ventricular pressure rises
2. **Ventricular ejection**: Semilunar valves open, blood ejected from ventricles

### Electrical Conduction System

**Components**:
- Sinoatrial (SA) node: Natural pacemaker (60-100 bpm)
- Atrioventricular (AV) node: Delays impulse (0.1 sec)
- Bundle of His: Conducts impulse to ventricles
- Bundle branches: Right and left bundle branches
- Purkinje fibers: Distribute impulse throughout ventricles

**Action Potential Phases**:
- Phase 0: Rapid depolarization (Na+ influx)
- Phase 1: Early repolarization (K+ efflux)
- Phase 2: Plateau (Ca²+ influx, K+ efflux)
- Phase 3: Repolarization (K+ efflux)
- Phase 4: Resting potential

### Hemodynamics

**Cardiac Output (CO)**: Volume of blood pumped per minute
- CO = Heart Rate × Stroke Volume
- Normal: 4-8 L/min

**Stroke Volume (SV)**: Volume ejected per beat
- SV = End Diastolic Volume - End Systolic Volume
- Normal: 70 mL

**Ejection Fraction (EF)**: Percentage of blood ejected
- EF = SV/EDV × 100
- Normal: 55-70%

**Frank-Starling Mechanism**: 
Increased venous return → increased preload → increased contractility → increased stroke volume

### Blood Pressure Regulation

**Mean Arterial Pressure (MAP)**:
- MAP = (2 × Diastolic + Systolic) ÷ 3
- MAP = CO × Total Peripheral Resistance

**Regulation Mechanisms**:

1. **Baroreceptor Reflex**:
   - Located in carotid sinus and aortic arch
   - Responds to stretch from increased pressure
   - Increases parasympathetic activity, decreases sympathetic activity

2. **Renin-Angiotensin-Aldosterone System (RAAS)**:
   - Activated by decreased renal perfusion
   - Renin → Angiotensin I → Angiotensin II
   - Effects: vasoconstriction, aldosterone release, ADH release

3. **Sympathetic Nervous System**:
   - α1 receptors: vasoconstriction
   - β1 receptors: increased heart rate and contractility
   - β2 receptors: vasodilation (skeletal muscle)

## Clinical Presentation

### Heart Sounds

**Normal Heart Sounds**:
- S1 ("lub"): Closure of AV valves, marks beginning of systole
- S2 ("dub"): Closure of semilunar valves, marks beginning of diastole

**Additional Heart Sounds**:
- S3 gallop: Ventricular filling, associated with heart failure
- S4 gallop: Atrial contraction against stiff ventricle

**Murmurs**:
- **Systolic murmurs**: Between S1 and S2
  - Aortic stenosis: Harsh, crescendo-decrescendo
  - Mitral regurgitation: Holosystolic, radiates to axilla
- **Diastolic murmurs**: Between S2 and S1
  - Aortic regurgitation: High-pitched, decrescendo
  - Mitral stenosis: Low-pitched, rumbling

### Electrocardiogram (ECG)

**Normal ECG Components**:
- P wave: Atrial depolarization
- QRS complex: Ventricular depolarization
- T wave: Ventricular repolarization
- PR interval: AV conduction time (0.12-0.20 sec)
- QT interval: Ventricular depolarization and repolarization

## Diagnosis

### Hemodynamic Parameters

**Preload**: Ventricular filling pressure
- Measured by: CVP (right), PCWP (left)
- Normal CVP: 2-8 mmHg
- Normal PCWP: 6-12 mmHg

**Afterload**: Resistance against ventricular ejection
- Right heart: Pulmonary vascular resistance
- Left heart: Systemic vascular resistance

**Contractility**: Intrinsic ability to contract
- Measured by: dP/dt, ejection fraction

### Cardiovascular Assessment

**Blood Pressure Measurement**:
- Normal: <120/80 mmHg
- Elevated: 120-129/<80 mmHg
- Stage 1 HTN: 130-139/80-89 mmHg
- Stage 2 HTN: ≥140/90 mmHg

**Pulse Pressure**: Systolic - Diastolic pressure
- Normal: 30-40 mmHg
- Wide pulse pressure: Aortic regurgitation, hyperthyroidism
- Narrow pulse pressure: Aortic stenosis, heart failure

## Treatment

### Cardiovascular Pharmacology

**Positive Inotropes**:
- Digoxin: Na+/K+-ATPase inhibition
- Dobutamine: β1 agonist
- Milrinone: Phosphodiesterase inhibitor

**Vasodilators**:
- ACE inhibitors: Block angiotensin II formation
- ARBs: Block angiotensin II receptors
- Calcium channel blockers: Block Ca²+ channels

**Diuretics**:
- Loop diuretics: Furosemide (Na+/K+/2Cl- cotransporter)
- Thiazides: NaCl cotransporter
- K+-sparing: Aldosterone antagonists

### Cardiac Resynchronization

**Pacemaker Therapy**:
- Single chamber: Atrial or ventricular pacing
- Dual chamber: AV synchrony
- Biventricular: Cardiac resynchronization therapy (CRT)

## Complications

### Heart Failure

**Systolic Heart Failure** (HFrEF):
- Reduced ejection fraction (<40%)
- Impaired contractility
- Symptoms: Dyspnea, fatigue, edema

**Diastolic Heart Failure** (HFpEF):
- Preserved ejection fraction (≥50%)
- Impaired relaxation/filling
- Similar symptoms to systolic failure

**Compensatory Mechanisms**:
- Frank-Starling mechanism
- Sympathetic activation
- RAAS activation
- Ventricular remodeling

### Arrhythmias

**Bradyarrhythmias**:
- Sinus bradycardia: <60 bpm
- AV blocks: First, second, third degree
- Sick sinus syndrome

**Tachyarrhythmias**:
- Supraventricular: Atrial fibrillation, SVT
- Ventricular: VT, VF
- Treatment: Antiarrhythmics, cardioversion, ablation

### Shock States

**Cardiogenic Shock**:
- Pump failure, low CO, high PCWP
- Causes: MI, cardiomyopathy, valve disease

**Hypovolemic Shock**:
- Low preload, low CO, low PCWP
- Causes: Hemorrhage, dehydration

**Distributive Shock**:
- Low afterload, high/normal CO
- Causes: Sepsis, anaphylaxis, neurogenic

## Prognosis

### Risk Stratification

**Cardiovascular Risk Factors**:
- Non-modifiable: Age, gender, family history
- Modifiable: Hypertension, diabetes, smoking, dyslipidemia

**Risk Calculators**:
- Framingham Risk Score
- ASCVD Risk Calculator
- GRACE Score (ACS)

### Heart Failure Prognosis

**NYHA Functional Class**:
- Class I: No symptoms with ordinary activity
- Class II: Slight limitation with ordinary activity
- Class III: Marked limitation with less than ordinary activity
- Class IV: Symptoms at rest

**Biomarkers**:
- BNP/NT-proBNP: Elevated in heart failure
- Troponin: Myocardial injury marker
- CK-MB: Cardiac-specific enzyme

## Key Points

1. **Cardiac Output** is determined by heart rate and stroke volume, regulated by preload, afterload, and contractility

2. **Frank-Starling Mechanism** ensures that venous return matches cardiac output through length-tension relationships

3. **Blood Pressure Regulation** involves baroreceptors, RAAS, and sympathetic nervous system working in concert

4. **Heart Failure** can be systolic (reduced EF) or diastolic (preserved EF) with different underlying mechanisms

5. **ECG Interpretation** requires understanding of electrical conduction and correlation with mechanical events

6. **Shock States** are differentiated by hemodynamic profiles: preload, afterload, and cardiac output measurements

7. **Cardiovascular Pharmacology** targets specific receptors and pathways to modify preload, afterload, heart rate, and contractility

8. **Risk Stratification** guides preventive measures and treatment intensity based on modifiable and non-modifiable factors

## References

1. Boron WF, Boulpaep EL. Medical Physiology. 3rd ed. Philadelphia: Elsevier; 2017.
2. Klabunde RE. Cardiovascular Physiology Concepts. 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2012.
3. Porth CM. Essentials of Pathophysiology. 4th ed. Philadelphia: Wolters Kluwer; 2015.
4. Mann DL, Zipes DP, Libby P, Bonow RO. Braunwald's Heart Disease. 10th ed. Philadelphia: Elsevier; 2015.
5. American Heart Association. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.